261 related articles for article (PubMed ID: 31361020)
21. Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis.
Buchy L; Seidman LJ; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Stone W; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
Psychiatry Res; 2015 Dec; 230(3):878-84. PubMed ID: 26626949
[TBL] [Abstract][Full Text] [Related]
22. No additive effect of cannabis on cognition in schizophrenia.
Power BD; Dragovic M; Badcock JC; Morgan VA; Castle D; Jablensky A; Stefanis NC
Schizophr Res; 2015 Oct; 168(1-2):245-51. PubMed ID: 26235754
[TBL] [Abstract][Full Text] [Related]
23. Trajectories of premorbid childhood and adolescent functioning in schizophrenia-spectrum psychoses: A first-episode study.
Horton LE; Tarbox SI; Olino TM; Haas GL
Psychiatry Res; 2015 Jun; 227(2-3):339-46. PubMed ID: 25829134
[TBL] [Abstract][Full Text] [Related]
24. Premorbid adjustment in first episode schizophrenia and schizoaffective disorders: a comparison of social and academic domains.
Norman RM; Malla AK; Manchanda R; Townsend L
Acta Psychiatr Scand; 2005 Jul; 112(1):30-9. PubMed ID: 15952943
[TBL] [Abstract][Full Text] [Related]
25. The Changing Legal Landscape of Cannabis Use and Its Role in Youth-onset Psychosis.
Wright A; Cather C; Gilman J; Evins AE
Child Adolesc Psychiatr Clin N Am; 2020 Jan; 29(1):145-156. PubMed ID: 31708043
[TBL] [Abstract][Full Text] [Related]
26. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
Di Forti M; Quattrone D; Freeman TP; Tripoli G; Gayer-Anderson C; Quigley H; Rodriguez V; Jongsma HE; Ferraro L; La Cascia C; La Barbera D; Tarricone I; Berardi D; Szöke A; Arango C; Tortelli A; Velthorst E; Bernardo M; Del-Ben CM; Menezes PR; Selten JP; Jones PB; Kirkbride JB; Rutten BP; de Haan L; Sham PC; van Os J; Lewis CM; Lynskey M; Morgan C; Murray RM;
Lancet Psychiatry; 2019 May; 6(5):427-436. PubMed ID: 30902669
[TBL] [Abstract][Full Text] [Related]
27. Premorbid adjustment in childhood is associated with later emotion management in first-episode schizophrenia.
Bridgwater MA; Horton LE; Haas GL
Schizophr Res; 2022 Feb; 240():233-238. PubMed ID: 35093858
[TBL] [Abstract][Full Text] [Related]
28. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.
Yücel M; Bora E; Lubman DI; Solowij N; Brewer WJ; Cotton SM; Conus P; Takagi MJ; Fornito A; Wood SJ; McGorry PD; Pantelis C
Schizophr Bull; 2012 Mar; 38(2):316-30. PubMed ID: 20660494
[TBL] [Abstract][Full Text] [Related]
29. Cannabis use and cognitive functions in at-risk mental state and first episode psychosis.
Bugra H; Studerus E; Rapp C; Tamagni C; Aston J; Borgwardt S; Riecher-Rössler A
Psychopharmacology (Berl); 2013 Nov; 230(2):299-308. PubMed ID: 23756588
[TBL] [Abstract][Full Text] [Related]
30. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
Ruiz-Veguilla M; Gurpegui M; Barrigón ML; Ferrín M; Marín E; Rubio JL; Gutiérrez B; Pintor A; Cervilla J
Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
[TBL] [Abstract][Full Text] [Related]
31. Moderating role of cannabis use between insight and depression in early psychosis.
Elowe J; Golay P; Baumann PS; Solida-Tozzi A; Conus P
Schizophr Res; 2020 Jan; 215():61-65. PubMed ID: 31780343
[TBL] [Abstract][Full Text] [Related]
32. Differences in cannabis-related experiences between patients with a first episode of psychosis and controls.
Bianconi F; Bonomo M; Marconi A; Kolliakou A; Stilo SA; Iyegbe C; Gurillo Muñoz P; Homayoun S; Mondelli V; Luzi S; Dazzan P; Prata D; La Cascia C; O'Connor J; David A; Morgan C; Murray RM; Lynskey M; Di Forti M
Psychol Med; 2016 Apr; 46(5):995-1003. PubMed ID: 26670601
[TBL] [Abstract][Full Text] [Related]
33. Associations between adolescent cannabis use and brain structure in psychosis.
Abush H; Ghose S; Van Enkevort EA; Clementz BA; Pearlson GD; Sweeney JA; Keshavan MS; Tamminga CA; Ivleva EI
Psychiatry Res Neuroimaging; 2018 Jun; 276():53-64. PubMed ID: 29628270
[TBL] [Abstract][Full Text] [Related]
34. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
[TBL] [Abstract][Full Text] [Related]
35. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
[TBL] [Abstract][Full Text] [Related]
36. Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis.
Arnold C; Allott K; Farhall J; Killackey E; Cotton S
Schizophr Res; 2015 Oct; 168(1-2):231-7. PubMed ID: 26260081
[TBL] [Abstract][Full Text] [Related]
37. Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort.
Setién-Suero E; Neergaard K; Ortiz-García de la Foz V; Suárez-Pinilla P; Martínez-García O; Crespo-Facorro B; Ayesa-Arriola R
Acta Psychiatr Scand; 2019 Oct; 140(4):349-359. PubMed ID: 31381129
[TBL] [Abstract][Full Text] [Related]
38. IQ as a predictor of functional outcome in schizophrenia: a longitudinal, four-year study of first-episode psychosis.
Leeson VC; Barnes TR; Hutton SB; Ron MA; Joyce EM
Schizophr Res; 2009 Jan; 107(1):55-60. PubMed ID: 18793828
[TBL] [Abstract][Full Text] [Related]
39. Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosis.
Del Rey-Mejías Á; Fraguas D; Díaz-Caneja CM; Pina-Camacho L; Castro-Fornieles J; Baeza I; Espliego A; Merchán-Naranjo J; González-Pinto A; de la Serna E; Payá B; Graell M; Arango C; Parellada M
Eur Child Adolesc Psychiatry; 2015 Dec; 24(12):1447-59. PubMed ID: 25726022
[TBL] [Abstract][Full Text] [Related]
40. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
